Related Experiment Video
Updated: Apr 30, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
Roberto Mariani1, Darlene Chen, Bärbel Schröfelbauer
1Infectious Disease Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
Abstract:
The HIV-1 accessory protein Vif (virion infectivity factor) is required for the production of infectious virions by CD4(+) lymphocytes. Vif facilitates particle infectivity by blocking the inhibitory activity of APOBEC3G (CEM15), a virion-encapsidated cellular protein that deaminates minus-strand reverse transcript cytosines to uracils. We report that HIV-1 Vif forms a complex with human APOBEC3G that prevents its virion encapsidation. HIV-1 Vif did not efficiently form a complex with mouse APOBEC3G. Vif dramatically reduced the amount of human APOBEC3G encapsidated in HIV-1 virions but did not prevent encapsidation of mouse or AGM APOBEC3G. As a result, these enzymes are potent inhibitors of wild-type HIV-1 replication. The species-specificity of this interaction may play a role in restricting HIV-1 infection to humans. Together these findings suggest that therapeutic intervention that either induced APOBEC3G or blocked its interaction with Vif could be clinically beneficial.
Insights
The HIV-1 Vif protein prevents APOBEC3G from being packaged into new viruses, stopping viral replication. This interaction is species-specific, potentially limiting HIV-1 to human hosts.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- The HIV-1 accessory protein Vif (virion infectivity factor) is crucial for producing infectious virions.
- Vif counters the antiviral activity of APOBEC3G, a cellular protein that inhibits viral replication by deaminating viral DNA.
Purpose of the Study:
- To investigate the interaction between HIV-1 Vif and human and non-human primate APOBEC3G.
- To understand the species-specificity of Vif-APOBEC3G interaction and its implications for HIV-1 restriction.
Main Methods:
- Complex formation assays between HIV-1 Vif and human/mouse/AGM APOBEC3G.
- Analysis of APOBEC3G encapsidation into HIV-1 virions in the presence of Vif.
Main Results:
- HIV-1 Vif forms a complex with human APOBEC3G, preventing its encapsidation into virions.
- HIV-1 Vif does not efficiently complex with mouse or AGM APOBEC3G, allowing their encapsidation.
- Human APOBEC3G potently inhibits wild-type HIV-1 replication, unlike mouse or AGM APOBEC3G.
Conclusions:
- The species-specific interaction between HIV-1 Vif and APOBEC3G restricts HIV-1 infection to humans.
- Therapeutic strategies targeting the Vif-APOBEC3G interaction or boosting APOBEC3G could be beneficial for HIV-1 treatment.
More Related Videos
07:22A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
13:07Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells
Published on: January 30, 2019
Related Concept Videos
Retroviruses
Viruses with RNA Genomes
Inhibitors of Viral Protein Synthesis